Commentary to “The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease”

[1]  A. Sahebkar,et al.  Safety of red yeast rice supplementation: A systematic review and meta‐analysis of randomized controlled trials , 2019, Pharmacological research.

[2]  F. Visioli,et al.  Pharmacology of Nutraceuticals with Lipid Lowering Properties , 2019, High Blood Pressure & Cardiovascular Prevention.

[3]  G. Costabile,et al.  The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease , 2019, High Blood Pressure & Cardiovascular Prevention.

[4]  F. Galletti,et al.  Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document , 2019, High Blood Pressure & Cardiovascular Prevention.

[5]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[6]  D. Francisci,et al.  NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial. , 2019, Atherosclerosis.

[7]  A. Sahebkar,et al.  Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk , 2018, Current Cardiology Reports.

[8]  R. Collins,et al.  Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks , 2018, JAMA cardiology.

[9]  C. von Schacky.  Rebuttal to Aung et al, "Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals". , 2018, Alternative therapies in health and medicine.

[10]  D. Panagiotakos,et al.  Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel , 2017, Nutrition reviews.

[11]  M. Rizzo,et al.  Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial , 2017, Advances in Therapy.

[12]  Alan D. Lopez,et al.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 , 2017, Journal of the American College of Cardiology.

[13]  F. Bernini,et al.  Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[15]  A. Sahebkar,et al.  The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. , 2016, Pharmacological research.

[16]  H. Tian,et al.  Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trials , 2016, The journal of nutrition, health & aging.

[17]  E. Mannarino,et al.  Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial , 2016, Scientific Reports.

[18]  R. Volpe,et al.  Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice , 2015, High Blood Pressure & Cardiovascular Prevention.

[19]  M. Volpe.  Cardiovascular Prevention: The Role of Second Generation of Nutraceuticals , 2015, High Blood Pressure & Cardiovascular Prevention.

[20]  M. Pirro,et al.  Nutraceuticals for the treatment of hypercholesterolemia. , 2014, European journal of internal medicine.

[21]  Baracco,et al.  The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[23]  E. Mannarino,et al.  Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.